Protection of organs other than the heart by remote ischemic conditioning by Candilio, L et al.
1 
 
Protection of organs other than the heart by 
remote ischemic conditioning 
 
Candilio L*, Malik A*, Hausenloy DJ 
 
 
 
*Dr Candilio and Dr Malik contributed equally and are joint first authors 
 
 
 
 
 
 
 
Corresponding author:  
Dr Derek J Hausenloy, 
The Hatter Cardiovascular Institute,  
University College London, 
67 Chenies Mews,  
London, WC1E 6HX, United Kingdom. 
Tel: +44 203 447 9888 
Fax: +44 203 447 5095 
Email: d.hausenloy@ucl.ac.uk 
*Manuscript (All Manuscript Text Pages in MS Word format, including Title Page, References and Figure Legends)
2 
 
Abstract 
Organ or tissue dysfunction due to acute ischemia-reperfusion injury (IRI) is the 
leading cause of death and disability worldwide. Acute IRI induces cell injury and 
death in a wide variety of organs and tissues in a large number of different clinical 
settings. One novel therapeutic non-invasive intervention, capable of conferring 
multi-organ protection against acute IRI, is ‘remote ischemic conditioning’ (RIC). This 
describes an endogenous protective response to acute IRI, which is triggered by the 
application of one or more brief cycles of non-lethal ischemia and reperfusion to one 
particular organ or tissue. Originally discovered as a therapeutic strategy for 
protecting the myocardium against acute IRI, it has been subsequently demonstrated 
that RIC may confer protection against acute IRI in a number of different non-cardiac 
organs and tissues including the kidneys, lungs, liver, skin flaps, ovaries, intestine, 
stomach and pancreas. The discovery that RIC can be induced non-invasively by 
applying the RIC stimulus to the skeletal tissue of the upper or lower limb, has 
facilitated its application to a number of clinical settings in which organs and tissues 
are at high-risk of acute IRI. In this article, we review the experimental studies which 
have investigated RIC in organs and tissues other than the heart, and we explore the 
therapeutic potential of RIC in preventing organ and tissue dysfunction induced by 
acute IRI. 
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1. Introduction 
Organ or tissue dysfunction arising from acute IRI is the leading cause of death and 
disability worldwide. Acute IRI induces cell injury and death in a large number of 
different clinical settings and in a wide variety of organs and tissues including the 
heart, kidneys, liver, intestine, lungs, brain, skeletal muscle, pancreas, skin, and 
ovaries. The pathophysiology of IRI and its effects on cellular function and viability 
are largely similar in these different organs and tissues. It follows then that novel 
therapeutic strategies for protecting against acute IRI appear to be similarly 
efficacious in these different organs and tissue. This appears to be the case with the 
endogenous protective response of remote ischemic conditioning (RIC), in which the 
application of one or more brief cycles of non-lethal ischemia and reperfusion in one 
organ or tissue confers protection in remote organs or tissues from a sustained lethal 
acute episode of IRI 1, 2. The majority of the experimental studies investigating RIC 
as a protective therapeutic strategy against acute IRI have revolved around the 
heart, and this topic is reviewed elsewhere in this special issue. In this article, we 
focus on the experimental studies which have investigated RIC in organs and tissues 
other than the heart, and we discuss the therapeutic potential application of RIC for 
preventing organ and tissue dysfunction in the clinical setting. 
 
2. Remote ischemic conditioning as an evolving protective strategy 
The discovery that the myocardium could be protected against a sustained lethal 
episode of acute IRI, by subjecting it to one or more brief cycles of non-lethal 
ischemia and reperfusion, was originally made in 1986 by Murry et al 3. This 
endogenous protective response against acute IRI, which was termed ‘ischemic 
preconditioning’ (IPC), has been reported to confer cross-species protection in all 
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organs and tissue it has been investigated in 4. However, the major disadvantage of 
IPC is the need to intervene before the index ischemic event, thereby limiting its 
clinical application 5. This was overcome by the introduction of the concept of 
ischemic postconditioning in 2003 by Zhao et al. 6 who demonstrated that 
interrupting myocardial reperfusion with several short-lived episodes of intermittent 
myocardial ischemia, so as to ‘stutter’ the reperfusion phase, could reduce 
myocardial infarct size in the canine heart, providing a therapeutic cardioprotective 
strategy which could be applied at reperfusion. However, the disadvantage of both 
IPC and IPost as treatment strategies is that both approaches require the 
intervention to be applied to the organ or tissue directly, which in some cases may 
not be feasible or practical 7. This obstacle was overcome by the discovery of 
‘remote ischemic preconditioning’ (RIPC) in 1993 1, a therapeutic strategy for 
protecting organs and tissues against acute IRI by applying the protective stimulus 
away from the target organ or tissue.  
The concept of protecting an organ or tissue against acute IRI at a distance 
was first conceived in a seminal experimental study in 1993 by Przyklenk et al 1. 
These authors demonstrated in the canine heart, that applying four 5-minute 
episodes of left circumflex branch occlusion and 5-minute reflow, reduced 
myocardial infarct (MI) size induced by 1 hour of sustained left anterior descending 
(LAD) coronary artery occlusion and 4.5 hours of reflow 1. The concept that 
protection against acute IRI could be transferred from one coronary artery territory to 
another was then extended to protecting the heart at a distance by applying the 
preconditioning stimulus to an organ ‘remote’ from the heart by McClanahan et al in 
1993 8. These authors demonstrated that subjecting the kidney to brief cycles of non-
lethal ischemia and reperfusion (IR) could limit subsequent MI size in the rat heart 8.  
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Later in 1997, Birnbaum et al 9 made the important discovery that RIPC could 
be induced by subjecting the skeletal muscle of the hind-limb to brief cycles of non-
lethal ischemia and reperfusion. These authors observed, that briefly restricting 
blood flow to the skeletal muscle of the lower limb and pacing the gastrocnemius leg 
muscle prior to an acute coronary artery occlusion, reduced MI size in the rabbit 
heart 9. A non-invasive method for applying the RIPC stimulus to the hind-limb using 
external compression with a tourniquet was then introduced by Oxman et al 10, a 
finding which has greatly facilitated the translation of RIPC as an experimental 
phenomenon into a potential non-invasive therapeutic strategy in the clinical setting. 
In this regard, the first clinical study to investigate RIPC in patients was by 
Gunaydin et al in 2000 11, who inflated and deflated a standard blood pressure cuff 
placed on the upper arm to non-invasively induce the RIC stimulus in patients prior 
to coronary artery bypass graft (CABG) surgery. However, the study was 
underpowered to detect any meaningful differences in the effect of RIC on peri-
operative myocardial injury. Later in 2002, Kharbanda et al 12 characterized in human 
volunteers a simple non-invasive RIPC protocol (three-5 min inflations/deflations of 
an upper arm blood pressure cuff) using flow-mediated dilatation as the measured 
endpoint of endothelial function.     
Crucially, experimental studies have demonstrated that the RIC stimulus does 
not have to be applied prior to the index ischemic event to be effective (as in ‘remote 
ischemic preconditioning’ or RIPC), but can be applied after the onset of index 
ischemia (termed ‘remote ischemic perconditioning’ or RIPerC) 13, and even at the 
time of reperfusion (termed ‘remote ischemic postconditioning’ or RIPost) 14, 15. The 
finding that the RIC stimulus can be effective when delivered at different time-points 
during the index episode of acute IRI has also increased it applicability to a number 
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of different clinical settings. The term, remote ischemic conditioning (RIC), has been 
introduced to refer to these different protective phenomena and will be used from this 
point forward.   
The recognition that a single RIC stimulus could confer multi-organ and tissue 
protection against acute IRI has led to it being extensively investigated not only in 
the field of myocardial protection but also in a wide variety of other non-cardiac 
organs or tissues such as the kidneys, lungs, liver, brain, stomach, intestine, 
pancreas and ovaries, in which acute IRI also causes significant morbidity and 
mortality. The mechanisms underlying RIC protection against acute IRI remain 
uncertain and are discussed elsewhere in this special issue. Throughout this review 
article, the reader will note the widely varying RIC protocols that have been used in 
the experimental studies. Unfortunately, insufficient work has been undertaken to 
ascertain the optimal RIC protocol in terms of its efficacy. If RIC is to succeed as a 
clinical applicable intervention both these issues will need to be addressed by further 
experimental study. 
 
3. Remote ischemic conditioning and the kidney 
Acute kidney injury (AKI) due to acute IRI is a frequent cause of morbidity and 
mortality following a number of medical conditions and operative procedures. AKI is 
a condition frequently encountered in the period that follows major surgery and which 
is associated with significant morbidity and mortality. In the setting of cardiac surgery 
it can affect up to 30% of patients resulting in renal dialysis, in 1-2% of cases 16, the 
repercussions of which include an eight-fold increase in death rate 17. AKI is also a 
common complication of major vascular surgery involving the abdominal aorta, and 
can occur in up to 10% of these patients 18, where it is an independent predictor of 
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death 19. Aortic cross-clamping and de-clamping during the surgical procedure 
subjects the kidneys to acute IRI 20. 
Different mechanisms have been hypothesized to explain the etiology 
underlying renal injury following cardiac surgery and these include hemodynamic 
effects related to cardiopulmonary bypass (CBP), metabolic factors, neuro-hormonal 
stimulation, the systemic inflammatory response to CBP, exogenous and 
endogenous toxins, and the production of micro-emboli and oxidative stress 16. 
Importantly, despite a number of different preventative strategies being investigated 
to preserve renal function following cardiac surgery, the results have been 
disappointing 16. Therefore, novel renoprotective strategies are required to protect 
the kidneys against acute IRI in order to reduce the incidence of AKI and improve 
clinical outcomes in these patients.  
  
3.1. The experimental data for RIC as a renoprotective strategy 
A number of experimental studies have investigated the effect of IPC as a 
therapeutic strategy for limiting acute renal IRI (reviewed in 21). However, only a few 
experimental studies have explored the effect of RIC in preventing acute IRI in the 
kidney (see Table 1a). Beneficial effects have been reported using a diverse variety 
of RIC protocols applied to different organs or tissues including the liver, small 
intestine, subphrenic aorta and the hindlimb. The study by Wever et al 22, which used 
limb RIC, attempted to characterize the RIC stimulus, and as expected they were 
able to show that the protective effect was augmented when the RIC stimulus was 
applied to both hindlimbs instead of one. Importantly, Kadkhodaee et al 23 
demonstrated that the RIC limb stimulus was effective even when applied after the 
onset of index renal ischemia (RIPerC) and even at the onset of renal reperfusion 
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(RIPost), thereby broadening the clinical application of RIC as a therapeutic 
renoprotective strategy. Finally, the concept of combining renoprotective stimuli has 
been recently investigated by Wever et al 24, who demonstrated the synergistic 
effects on preserving renal function using RIPost and a local IPost protocol in 
combination.   
 
3.2. The clinical data for RIC as a renoprotective strategy 
Several clinical studies have investigated the effect of RIC using repeated cycles of 
upper arm or leg ischemia and reperfusion on preventing renal dysfunction and the 
development of acute kidney injury (AKI) following a number of medical and surgical 
procedures including percutaneous coronary intervention (PCI), CABG surgery, renal 
transplantation, abdominal aortic aneurysm surgery, and other major vascular 
surgery (see Table 1b). However, not all the clinical studies have reported a 
beneficial effect of RIC as a renoprotective strategy with some studies being neutral. 
The reasons for the mixed results are multi-factorial and have been discussed in 
relation to myocardial protection in several recently published articles 25-28. The 
majority of the clinical studies have investigated the protective effect of RIC against 
acute renal IRI, although a recently published trial reported beneficial effects against 
contrast-induced AKI during elective PCI 29, a condition which affects up to 12% of 
patients with coronary heart disease (CHD) undergoing elective PCI.  
Whether RIC can actually improve clinical outcomes following acute renal IRI is 
currently being investigated in two large multi-centre randomized controlled clinical 
trials. The ERICCA trial (ClinicalTrials.gov Identifier: NCT01247545), is currently 
investigating the effect of RIC (four-5 min upper arm cuff inflations/deflations) on 
post-operative renal function, renal biomarkers, the development of AKI, and major 
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adverse cardiovascular events in adult patients undergoing CABG plus or minus 
valve surgery 30. The REPAIR trial (ISRCTN30083294) is currently investigating the 
effect of RIC (three-5 min upper arm cuff inflations/deflations) applied to both the 
donor and recipient on post-operative renal function and renal biomarkers in patients 
undergoing live donor-related renal transplantation. 
 
4. Remote ischemic conditioning and the lungs 
Acute lung injury is a major cause of morbidity and mortality in a number of clinical 
settings including cardiac surgery, orthopedic surgery, lung resection surgery and 
lung transplantation. In the setting of CABG surgery, the main contributory 
mechanisms underlying pulmonary dysfunction include cardiopulmonary bypass 
(CBP)-induced systemic cytokine-mediated inflammatory response and acute lung 
IRI 31, resulting in poor alveolar oxygenation and increased pulmonary vascular 
resistance leading to prolonged requirement for artificial ventilation 32, 33.  
 
4.1. The experimental data for RIC as a lung protective strategy 
One of the first experimental studies to investigate the effect of RIC on acute lung 
injury was by Peralta et al in 2002 34 who demonstrated in the rat that applying a RIC 
stimulus to the liver reduced systemic inflammation and attenuated neutrophil 
accumulation in the lung and other organs following a sustained liver IRI. Since this 
study a number of studies have examined the effect of RIC in preventing acute lung 
IRI in a wide variety of experimental models (see Table 2a). 
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4.2. The clinical data for RIC as a lung protective strategy 
A number of clinical studies have investigated the effect of RIC on pulmonary 
function following mainly cardiac surgery, although there has been one study in 
orthopaedic surgery (see Table 2b). The first clinical study to demonstrate a 
beneficial effect of RIC on pulmonary function was by Li et al in 2001 35 who 
demonstrated that RIC of the heart could preserve pulmonary function following adult 
cardiac valve surgery. However, in the majority of the clinical studies, the main 
objective has been to evaluate the effect of RIC on cardioprotection, and the 
endpoints of pulmonary function, were usually secondary objectives of the study. In 
this regard, RIC appears to have some beneficial effects on preserving pulmonary 
function in pediatric cardiac surgery and following orthopedic surgery. However, it 
appears that RIC has little effect on ventilation times following adult cardiac surgery, 
which may be expected given that there are a large number of factors other than 
acute IRI which contribute to the length of ventilation post-cardiac surgery. It will be 
interesting to examine the effect of RIC in clinical settings in which acute lung IRI is 
the predominant insult such as in cases of lung resection surgery and lung 
transplantation. In this regard, on-going clinical studies are currently evaluating the 
effects of RIC on pulmonary function in the setting of pulmonary lobectomy 
(ClinicalTrials.gov identifier: NCT01307085) and elective abdominal aortic aneurysm 
repair (ClinicalTrials.gov NCT01344239). 
 
5. Remote ischemic conditioning and the liver 
During major liver surgery, intra- or post-operative blood loss with subsequent 
requirement of blood transfusion is associated with worse clinical outcomes 36, 37. 
Vascular clamping of the hepatic territory can prevent or minimise this risk although it 
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is itself associated with acute liver IRI due to clamping and subsequent unclamping 
of the portal triad 38, 39. The mechanism underlying acute hepatic IRI is likely to be 
related to the significant amount of oxygen-derived free radicals accumulating in the 
liver during reperfusion, particularly in those cases of resected or cirrhotic liver when 
acute IRI is poorly tolerated due to impaired compensatory mechanisms, leading to 
post-operative hepatic and multi-organ failure 38. 
 
5.1. The experimental data for RIC as a liver protective strategy 
The first experimental study to demonstrate benefit with limb RIC was by Lai et al 40 
who found that four-10 min cycles of hind-limb ischemia and reperfusion reduced 
acute liver IRI as evidenced by an attenuated increase in the serum liver enzyme 
ALT (alanine aminotransferase). In this initial study, RIC protection was associated 
with the activation of hemoxygenase-1 (HO-1), a known mediator of direct IPC 40. 
Since this publication, a number of experimental studies, using a wide variety of 
different RIC protocols, have confirmed the protective effects of limb RIC against 
acute liver IRI in the rat, rabbit and mouse (see Table 3 for summary). The 
mechanism underlying the protective effect is unclear, although potential mediators 
include components of the nitric oxide pathway (sGC, cGMP, eNOS)  41-43   and the 
Toll-4 receptor signalling pathway. An exciting recent study has suggested that limb 
RIC may not only be able to protect against acute liver IRI, but it may actually 
promote liver regeneration in small liver grafts following liver transplantation 44. Wang 
et al 44 demonstrated that a standard limb RIC protocol increased the proliferation 
index in the liver graft, findings which were associated with enhanced expression of 
interleukin-6 mRNA and suppressed expression of TNF-α. 
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5.2. The clinical data for RIC as a liver protective strategy 
Two randomised controlled clinical trials are currently investigating the therapeutic 
potential of RIC in the clinical setting of acute hepatic IRI. In the first study, based in 
the UK, Davidson and colleagues are exploring whether RIC (three-10 min cycles 
thigh cuff inflation/deflation) can reduce acute liver IRI (serum hepatic and tissue 
biomarkers) in patients undergoing liver surgery and orthotopic liver transplantation 
(ClinicalTrials.gov identifier: NCT00796588). In the second study, based in the USA, 
Koneru and colleagues will evaluate short and long-term clinical outcomes in 
patients receiving liver, kidney or pancreas transplantation from deceased organ 
donors previously randomised to either RIC (two-10 min cycles of inflation/deflation 
of a blood pressure cuff applied sequentially on each leg) (Remote Ischemic 
Preconditioning In Abdominal Organ Transplantation [RIPCOT]; ClinicalTrials.gov 
identifier: NCT00975702). The results from these two studies should inform us of the 
therapeutic potential of RIC in preventing acute liver IRI in patients undergoing major 
abdominal surgery or organ transplantation. 
 
6. Remote ischemic conditioning and the brain 
There are a number of clinical settings in which the brain is subjected to acute IRI 
including the setting of stroke and during carotid endarterectomy (CEA). Stroke is 
currently the second most common cause of death worldwide, after coronary artery 
disease 45, and is responsible for nearly 10% of all deaths around the world 46. In 
2002, stroke-related disability was estimated as the fifth most common cause of 
reduced disability-adjusted life-years (DALYs—the sum of life-years lost as a result 
of premature death and years lived with disability adjusted for severity) in low-income 
and middle-income countries 46. CEA has been recognised as an effective strategy 
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for stroke prevention in both symptomatic and asymptomatic patients 47-50. However 
CEA itself carries important peri-operative risks, with an estimated mortality rate of 
1%, perioperative stroke rate of 3-5%, and a major cardiac complication rate 
(myocardial infarction, unstable angina, pulmonary edema, or ventricular 
tachycardia) of 4% 51, 52.  
 
6.1. The experimental data for RIC as a neuroprotective strategy 
As a potentially novel neuroprotective intervention, RIC has been extensively studied 
in the pre-clinical literature. Experimental studies have evaluated RIC from a number 
of different perspectives: (1) a number of different species have been investigated 
including mouse, rat, rabbit and pig; (2) the timing of the RIC stimulus in relation to 
the acute IRI; (3) site of the RIC stimulus (mainly the limb but also other organs); (4) 
A variety of conditions including acute brain IRI (cerebral infarction, cerebral 
asphyxia, hypothermic circulatory arrest, and neonatal cerebral hypoxia) and spinal 
injury (Table 4). The first experimental study to evaluate RIC as a neuroprotective 
strategy was by Dave et al 53 who found that RIC (either a single episode of 15 or 30 
minutes of hindlimb ischemia and reperfusion) could protect the rat brain against 
acute IRI induced by asphyxial cardiac arrest. Crucially, the RIC stimulus has been 
shown to be effective at a number of different time-points in relation to the cerebral 
IRI broadening its scope for application in the clinical setting. The RIC stimulus can 
be applied one or two days prior to the index cerebral ischemia (delayed RIPC), 
immediately prior to the index cerebral ischemia (classical RIPC), after the onset of 
the index cerebral ischemia (RIPerC), at the onset of cerebral reperfusion (RIPost) 54 
and even when delayed up to 3 hours into the reperfusion phase (delayed RIPost) 54 
(Table 4). The ability to protect the brain against acute IRI with the RIC delivered 3 
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hours into reperfusion would have important clinical implications. Whether delaying 
the RIC stimulus into reperfusion is effective in protecting other organs or tissue 
against acute IRI is unknown, although this approach does appear to contradict the 
current paradigm that, for a protective intervention to be effective it needs to be 
applied at the onset of reperfusion. Interestingly, a recent experimental study has 
demonstrated that local IPost applied direct to the heart could limit myocardial infarct 
size in a murine model of acute IRI, even when delivered up to 30 min into 
reperfusion 55. 
 
6.2. The clinical data for RIC as a neuroprotective strategy 
Several small proof-of-concept randomised controlled clinical trials have been 
published investigating the neuroprotective effect of limb RIC. In a phase 1b study, 
Koch et al 56 demonstrated that RIC could be safely applied to 33 critically ill subjects 
presenting with aneurysmal subarachnoid haemorrhage (SAH). Hu et al 57 
demonstrated significant reductions of post-operative serum markers of cerebral 
ischemic injury (S-100B and neurone-specific elonase) and improvements in 
neurological recovery in 20 patients with cervical spondylotic myelopathy undergoing 
elective cervical decompression, when compared to similar control subjects. Walsh 
et al 58 evaluated the effects of RIC (10 minutes of ischemia-reperfusion applied with 
a blood pressure cuff sequentially to each leg) prior to clamping of the carotid artery 
in 70 patients undergoing elective CEA. This study failed to demonstrate any 
significant effect on saccadic latency deteriorations (a marker of cerebral injury 
following CEA). A recent clinical trial has evaluated the effect of RIC (four-5 min arm 
cuff inflations/deflations) on cerebral infarct size in 151 acute ischemic stroke 
patients undergoing thrombolysis, but this ground-breaking clinical trial failed to find 
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any significant effect on cerebral infarct size or neurological recovery 59. There are 
currently a number of on-going clinical trials (www.clinicaltrials.gov) investigating the 
neuroprotective potential of RIC in a wide variety of clinical settings including 
pediatric and adult cardiac surgery.  
 
7. Remote ischemic conditioning and other organs and tissues 
7.1. Remote ischemic conditioning and the gastrointestinal system 
The intestine, stomach and pancreas are all vulnerable to the detrimental effects of 
acute IRI. Of these the intestine is most commonly affected by acute IRI in a number 
of clinical settings including cardiac arrest 60, hemorrhagic shock 61, burn trauma 62, 
and major vascular and cardiac surgery 63-65, the effects of which are increased 
intestinal epithelial barrier permeability and translocation of pathogenic bacteria and 
endotoxins 66 with subsequent inflammation, sepsis and multi-organ failure 67.  
 In 2002, Dickson et al 68 were the first to report that RIC of the rabbit heart 
could protect jejunal intestinal contractile function, beneficial effects which were 
blocked in the presence of either naloxone or glibenclamide, thereby implicating 
possible involvement of opioids and the KATP channel, known mediators of 
cardioprotection. Saeki et al 69 went on to demonstrate that RIC (15 minute infrarenal 
aortic occlusion and reflow) could protect against intestinal IRI in rats receiving small 
bowel transplantation. Interestingly, Zitta et al 70 demonstrated that serum from 
human volunteers treated with RIC (four-5 minute cycles of arm ischemia and 
reperfusion) protected intestinal cells against simulated IRI via 
matrixmetalloproteinase (MMP)-2 and MMP-9. Brzozowski et al 71 were the first to 
demonstrate that RIC (two-5 min cycles of myocardial or hepatic ischemia and 
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reperfusion) could protect the stomach against acute IRI. RIC gastric protection was 
found to be abrogated in capsaicin-denervated or vagotomised rats.  
Combined pancreas-kidney transplantation has recently been successfully 
implemented for patients with type 1 diabetes and end-stage renal failure 72. This 
operation can be complicated by graft pancreatitis, a contributing factor of which is 
acute IRI, resulting in graft loss 73. Oehmann et al 74 were the first to demonstrate 
that RIC (15 minutes of infrarenal aortic ischemia and reperfusion) could protect the 
pancreas against acute IRI as evidenced by improved circulation, reduced 
inflammatory tissue response and histology damage. RIC-mediated protection 
against acute pancreatic IRI has been confirmed by a subsequent study 75, although 
not all studies have been positive 76.  
In terms of clinical application, a large randomised controlled clinical trial is 
underway investigating the effect of RIC on clinical outcomes following combined 
liver, kidney or pancreas transplantation (ClinicalTrials.gov identifier: NCT00975702). 
 
7.2. Remote ischemic conditioning and skin flaps 
In the setting of trauma, plastic and reconstructive surgery, soft tissue coverage is 
usually performed with the use of local or free skin flaps, a surgical procedure which 
is associated with significant morbidity due to the risk of necrosis of the implanted 
flap in 1-5% of cases 77, 78. This is likely to be caused by prolonged post-operative 
flap ischemia when the flap is exposed to during the surgery. Küntscher et al 79-81 
were the first to demonstrate that hindlimb RIC (10 min clamping of femoral artery) 
could protect muscle flaps against IRI. Whether, this RIC is beneficial in the clinical 
setting of plastic surgery is currently being tested in patients undergoing skin flap 
transplantation to the anterolateral thigh (ClinicalTrials.gov identifier: NCT01235286). 
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It is interesting to note that upper arm RIC has been recently demonstrated to 
improve cutaneous tissue oxygen saturation, arterial capillary blood flow and post-
capillary venous filling pressure in the skin of the contralateral thigh in human 
volunteers 82.  
 
7.3. Remote ischemic conditioning and the ovaries 
Ovarian auto-transplantation is an increasingly used procedure for maintaining 
fertility in women receiving cytotoxic treatment for malignant disease or 
immunosuppressive disorders, which ultimately cause early ovary failure 83, 84. This 
has been observed in up to 34% of women receiving chemotherapy and 92% of 
patients having radio- or chemo-therapy for bone marrow transplantation 85. Acute 
IRI of the graft ovary is one of the major factors responsible for preventing graft 
revascularization and success of ovarian transplantation 86. It has been 
demonstrated that hindlimb RIC in the rat improves ovarian viability, vascularization 
and vasodilatation, findings which were associated with increased serum oestradiol 
levels, improved graft morphology and follicular maturity 87, 88. This novel application 
of RIC in improving the success of ovarian transplantation remains to be explored in 
the clinical setting. 
       
8. Conclusions 
Although remote ischemic conditioning (RIC) was first discovered as a non-invasive 
therapeutic strategy for protecting the heart from a distance, its potential for 
conferring widespread protection against acute IRI in a number of different non-
cardiac organs and tissues has now been realized. Experimental studies have 
demonstrated beneficial effects of RIC against acute IRI in a wide variety of organs 
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and tissues including kidney, liver, brain, skin flaps, ovaries, intestine, stomach and 
the pancreas. Further study is now needed to characterize the optimal RIC protocol 
in terms of efficacy and to elucidate the mechanisms underlying its protective effect. 
The ability to induce RIC by simply applying the protective stimulus to the arm or leg 
has facilitated it translation into a number of clinical settings in which vital organs 
such as the kidney, brain and liver are vulnerable to acute IRI. Large multi-centre 
randomized controlled clinical trials are needed to investigate whether RIC can 
improve clinical outcomes in patients at risk of IRI-induced organ and tissue 
dysfunction.  
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Figure legend 
This figure demonstrates the non-cardiac organs and tissue in which remote ischemic 
conditioning (RIC, inflations and deflations of a blood pressure cuff placed on the upper arm 
or thigh to induce cycles of non-lethal ischemia and reperfusion) may offer protection against 
acute ischemia-reperfusion injury (IRI). In each organ and tissue, there are number of clinical 
settings in which RIC has been or is currently being investigated as a therapeutic strategy or 
in which the potential for clinical application exists. 
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Table 1a: Major experimental studies investigating the effect of RIC on preventing acute 
renal IRI  
Experimental  
study 
Experimental setting RIC protocol Result of RIC 
Ates et al 2002 
89
 Rat model of renal acute IRI  
(45 min I /24 hr R) 
 
One-10 min cycle of hepatic 
IR 
Reduced BUN levels at 24 hours and improved 
histological changes. 
 
 
Song et al 2007 
90
 Rat model of renal acute IRI  
(45 min I /24 hr R) 
 
Three-cycles of 8 min I and 5 
min R of small intestine     
Reduced levels of Cr, BUN and less renal 
morphologic change. 
 
Lazaris et al 2009 
91
 Rat model of renal acute IRI  
(45 min aortic cross-clamp/45 
min R) 
 
One-15 min cycle of aortic 
clamping and declamping  
Reduced levels of renal blood lactate and MDA 
and less renal tissue MDA. 
 
Kadkhodaee et al 
2011 
23
 
Rat model of renal acute IRI  
(45 min I /24 hr R) 
 
Four-5 min cycles of IR to one 
hindlimb during acute renal 
ischemia (RIPerC) and at the 
onset of reperfusion (RIPost).  
    
Reduced Cr and BUN levels at 24 hours. 
 
 
Wever et al 2011 
22
 Rat model of renal acute IRI  
(25 min I /48 hr R) 
Four RIC protocols prior to 
acute renal IRI: One-12 min or 
three-4 min cycles of IR to one 
or both hind-limbs.     
All RIC protocols except 12 min IR to one limb 
improved renal function. Protective effect 
dependant on tissue mass. 
 
Wever et al 2012 
24
 Rat model of renal acute IRI  
(25 min I /48 hr R) 
Three-5 min cycles of IR to 
both hindlimbs at the onset of 
reperfusion (RIPost). 
Improved renal function. RIC effect synergistic 
with local IPost 
 
I-ischemia, R-reperfusion, IR-ischemia and reperfusion, IRI-ischemia-reperfusion injury, RIC-remote ischemic conditioning, RIPerC- remote 
ischemic perconditioning, RIPost- remote ischemic postconditioning, IPost- ischemic postconditioning, BUN-blood urea nitrogen, Cr-creatinine, 
MDA- malondialdehyde 
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Table 1b: Major clinical studies investigating the effect of RIC on preventing acute renal IRI 
Clinical study Clinical setting N  RIC protocol Result of RIC 
Ali et al 2007 
92
 Elective AAA repair  82 10 min clamping of the right 
common iliac artery 
followed by clamping of the 
left common iliac artery.  
23% absolute risk reduction in the 
incidence of renal impairment (defined as 
peak serum Cr level of 177 µmol/L (2.0 
mg/dL)). 
 
Walsh et al 2009 
93
 
Elective EVAR 40 10min cuff inflation of the 
right thigh followed by 10 
min cuff inflation of the left 
thigh. 
Attenuated increase in the renal injury 
biomarker, urinary retinol binding protein, 
and a non-significant reduction in the 
urinary albumin:Cr ratio. 
 
Walsh et al 2010 
94
 
Elective open infrarenal AAA repair 40 10 min clamping of the right 
common iliac artery 
followed by clamping of the 
left common iliac artery. 
No effect on either urinary retinol binding 
or albumin:Cr ratio 
Venugopal et al 
2010 
95
 
Adult CABG surgery 78 Three-5 min upper arm cuff 
inflations/deflations 
Retrospective study showing a reduction 
in the incidence of AKI (according to AKIN 
criteria) from 25 to 11%.  
 
Thielmann et al 
2010
 96
 
 
Adult CABG surgery  53 Three-5 min upper arm cuff 
inflations/deflations 
 
No overall difference in Cr levels and 
eGFR over 72 hrs. 
Improved post-operative peak Cr levels in 
RIC group 
Lower post-operative minimum eGFR in 
control group.  
 
Rahman et al 
2010 
97
 
Adult CABG surgery 162 Three-5 min upper arm cuff 
inflations/deflations 
 
No effect on AKI or renal biomarkers 
Choi et al 2011 
98
 Adult complex valve surgery 76 Three-10 min thigh cuff 
inflations/deflations 
 
No effect on AKI or renal biomarkers 
(serum Cr, cystatin C and NGAL). 
Zimmerman et al 
2011 
99
 
Adult CABG surgery 120 Three-5 min thigh cuff 
inflations/deflations 
Reduction from 47% to 20% in the 
incidence of AKI (defined as an increase 
in serum Cr levels by at least 0.3 mg/dL or 
50% more than the baseline value within 
48 hr of surgery).  
No difference in plasma NGAL at 3 hours.  
Pedersen et al 
2011 
100
 
Paediatric cardiac surgery for 
complex congenital heart disease 
103 Four-5 min thigh cuff 
inflations/deflations 
 
No effect on AKI or renal biomarkers. 
Whittaker et al 
2011 
101
 
Adult patients with mildly impaired 
renal function undergoing primary 
PCI  
43 >4 inflations/deflations of 
angioplasty balloon 
Retrospective study showing preserved 
renal function in those receiving 
angioplasty balloon inflations/deflations at 
time of primary PCI. 
Hong et al 2012 
102
 
Adult OPCABG surgery 70 Four-5 min cycles of thigh 
cuff ischemia and 
reperfusion prior to after 
anastomoses. 
No difference in post-operative renal 
dysfunction 
Er et al 2012 
29
 Adult patients with moderately 
impaired renal function undergoing 
elective PCI  
100 Four-5 min upper arm cuff 
inflations/deflations 
Reduction from 40% to 16% in the 
incidence of contrast-AKI (defined as an 
increase in serum Cr ≥25% or ≥0.5 mg/dL 
above baseline at 48 hr 
AAA- abdominal aortic aneurysm, EVAR- endovascular aortic aneurysm repair, CABG- coronary artery bypass graft, PCI- percutaneous  
coronary intervention, OPCABG- off-pump coronary artery bypass graft, RIC-remote ischemic conditioning, Cr- creatinine, µmol- micromoles, L-
litre, dL- decilitre, mg- milligram, AKI- acute kidney injury, AKIN- acute kidney injury network, NGAL- neutrophil gelatinase-associated lipocalin, 
eGFR- estimated glomerular filtration rate 
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Table 2a: Major experimental studies investigating the effect of RIC on preventing acute 
lung IRI  
Experimental  
study 
Experimental setting RIC protocol Result of RIC 
Peralta et al 2001 
34
 
Rat model of acute liver acute 90  
(90 min I /R) 
 
One-10 min cycle of hepatic 
IR  
Attenuated neutrophil accumulation in lungs. 
 
Harkin et al 2002 
103
 
Porcine model of acute lung IRI (2 
hr I /2.5 hr R) 
 
Three-5 min cycles of bilateral 
hindlimb IR     
Reduced markers of systemic inflammation (TNF 
and interleukin-6, and attenuated phagocytic cell 
priming and pulmonary oedema/respiratory 
failure. 
 
Xia et al 2003 
104
 Sheep model of repeated 
myocardial ischemia induced by 10 
min clamping of LAD, LCx then 
RCA. 
 
Three-5 min cycles of iliac 
artery IR     
Attenuated increase in pulmonary vascular 
resistance and pulmonary artery pressure and a 
smaller reduction in PaO2 
Waldow et al 2005 
105
 
Porcine model of acute lung IRI 
(1.5 hr I /5 hr R) 
 
Three-5 min cycles of left 
common femoral artery IR     
Prevention of acute lung IRI and pulmonary 
hypertension. 
Olguner et al 2006 
106
 
Rat model of acute hindlimb IRI (4 
hr I /2 hr R) 
 
Three-10 min cycles of 
hindlimb IR  
Attenuated neutrophil accumulation in lungs. 
Reduced histological changes in lung. 
Kharbanda et al 
2006 
107
 
Porcine model of cardiopulmonary 
bypass 
Four-5 min cycles of hindlimb 
IR 
Improved lung compliance, attenuated increase 
in pulmonary resistance and a lower peak 
inspiratory pressure. 
 
I-ischemia, R-reperfusion, IR-ischemia and reperfusion, IRI-ischemia-reperfusion injury, LAD- left anterior descending, LCx- left circumflex, RCA- 
right coronary artery, RIC-remote ischemic conditioning ,TNF- tissue necrosis factor, PaO2- partial pressure of oxygen  
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Table 2b: Major clinical studies investigating the effect of RIC the effect of RIC on preventing 
acute lung IRI 
Clinical study Clinical setting N  RIC protocol Result of RIC 
Li et al 2001 
35
 Adult CABG surgery 
 
40 Two cycles of 3 min aortic 
cross clamping and 2 min 
declamping 
Reduced ventilation requirements, 
pulmonary oedema and haemorrhage, 
and decreased leukocyte count found on 
lung biopsies taken after 1 hour of 
reperfusion. 
 
Cheung et al 2006 
108
 
 
Pediatric cardiac surgery for 
congenital heart disease  
37 Four-5 min cycles of thigh 
cuff ischemia and 
reperfusion   
 
Lower airway resistance at 6 hr 
postoperatively.  
Rahman et al 
2010 
97
 
Adult CABG surgery 162 Three-5 min cycles of arm 
cuff ischemia and 
reperfusion 
No effect on ventilation time and 
preoperative and postoperative PaO2/FiO2   
ratios. 
 
Zhou et al 2010
 109
 Pediatric cardiac surgery for 
congenital heart disease 
60 Three-5 min cycles of arm 
cuff ischemia and 
reperfusion 24 hrs and 1 hr 
pre-operatively 
  
Better lung compliance (Cs) and dynamic 
lung compliance. 
Li et al 2010 
110
 Adult valvular heart surgery 81 Three-4 min cycles of thigh 
cuff ischemia and 
reperfusion 
No effect on ventilation time. 
 
Thielmann et al 
2010 
96
 
Adult CABG surgery 53 Three-5 min cycles of arm 
cuff ischemia and 
reperfusion 
 
No effect on ventilation time. 
 
Lin et al 2010 
111
 Lower limb orthopaedic surgery 
with 75 min lower leg ischemia. 
30 Three-5 min cycles of leg 
cuff ischemia and 
reperfusion 
 
Reduced pulmonary injury. 
Young et al 2012 
112
 
Adult high-risk CABG surgery 96 Three-5 min cycles of arm 
cuff ischemia and 
reperfusion 
 
Increased ventilation time 
Hong et al 2012 
102
 
Adult OPCAB surgery 70 Four-5 min cycles of thigh 
cuff ischemia and 
reperfusion prior to after 
anastomoses. 
 
No effect on PaO2/FiO2   ratio 
Kim et al 2012 
113
 Adults complex valvular heart 
surgery 
54 Three-10 min cycles of 
thigh cuff ischemia and 
reperfusion prior to after 
bypass. 
No effect on PaO2/FiO2 or incidence of 
acute lung injury (was defined as 
PaO2/FiO2 <300 mmHg, the detection of 
bilateral pulmonary infiltrates on frontal 
chest radiography and no clinical evidence 
of further elevation in the left atrial 
pressure. 
 
Lomivorotov et al 
2012 
114
 
Adult CABG surgery 80 Three-5 min cycles of arm 
cuff ischemia and 
reperfusion 
 
No effect on ventilation time 
CABG- coronary artery bypass graft, OPCABG-off-pump coronary artery bypass graft, RIC-remote ischemic conditioning, PaO2/FiO2-oxygen 
tension/Fraction of inspired oxygen ratio, Cs- static compliance, mmHg- millimetres of mercury 
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Table 3: Major experimental studies investigating the effect of RIC on preventing acute liver 
IRI  
Experimental  
study 
Experimental setting RIC protocol Effect of RIC 
Lai et al 2006 
40
 Rat model of partial liver (left lobe 
only) IRI 45 min I/240 min R 
Four-10 min cycles of IR to 
hindlimb   
Attenuated increase in serum ALT. 
Increased hepatocyte expression of HO-1 
  
 
Kanoria et al 2006 
115
 
Rabbit model of liver acute IRI 25 
min I/ 120 min R 
 
Three-10 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels  
Preserved PLBF  
Increased hepatic nitrite/nitrate levels.  
 
Gustaffson et al 
2006 
116
 
Rat model of  
mild liver IRI 60 min I/60 min R 
(occlusion of hepatic artery only) 
severe liver IRI 60 min I/60 min R 
(occlusion of hepatic vascular 
supply). 
 
One 10 min episode of 
hindlimb ischemia  
 
Attenuated increase in serum ALT levels but no 
difference in PLBF following mild ischemia. No 
difference in ALT or PLBF in severe hepatic 
ischemia. 
 
Tapuria et al 2009 
117
 
Rat model of partial liver IRI  
45 min I/180 min R 
Four-4 min cycles of IR to 
hindlimb   
Increased red blood cell velocity, sinusoidal flow 
and sinusoidal perfusion along with decreased 
neutrophil adhesion and cell death.  
 
Wang et al 2010 
41
 Murine model of partial liver 
ischemia 60 min I/R 
One 10 min episode of 
hindlimb ischemia.   
Attenuated increase in serum ALT. 
Reduced serum and hepatocyte expression of 
TNF-α, and less apoptotic cell death. 
Increased expression of serum HMG-B1, which 
acts on TLR4. 
No RIC in TLR4 deficient mice. 
 
Abu-Amara et al 
2011 
118
 
Murine model of partial liver acute 
IRI 40 min I/ 120 min R 
Six-4 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels. 
Preserved electron microscopic/histological 
appearances  
RIC blocked by NO inhibitor 
 
Abu-Amara et al 
2011 
42
 
Murine model of partial liver acute 
IRI 40 min I/ 120 min R 
Six-4 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels. 
Preserved electron microscopic/histological 
appearances  
No RIC in eNOS deficient mice. 
 
Kanoria et al 2012 
119
  
Rabbit model of liver acute IRI 25 
min I/ 120 min R 
 
Three-10 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels  
Increased mitochondrial oxygenation, and 
elevated serum bicarbonate and hepatic 
nitrite/nitrate levels.  
 
Abu-Amara et al 
2012 
43
 
Murine model of partial liver acute 
IRI 40 min I/ 120 min R 
 
Six-4 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels  
Preserved electron microscopic/histological 
appearances  
RIC dependant on sGC-cGMP  
 
Wang et al 2012 
44
 Rat model of liver graft 
transplantation 
Four-4 min cycles of IR to 
hindlimb   
Attenuated rise in ALT/AST levels. 
Preserved electron microscopic/histological 
appearances. 
Increased graft proliferation and enhanced 
expression of interleukin-6 mRNA and 
suppressed expression of TNF-α. 
 
I-ischemia, R-reperfusion, IR-ischemia and reperfusion, IRI-ischemia-reperfusion injury, RIC-remote ischemic conditioning, ALT- alanine 
aminotransferase, AST- aspartate aminotransferase, HO-1- hemoxygenase-1, PLBF- peripheral liver blood flow, TNF-α - tissue necrosis factor 
alpha, HMG-B1- High Mobility Group-Box 1, TLR4- toll-like receptor-4, NO- nitric oxide, eNOS- endothelial nitric oxide synthase, sGC- soluble 
guanylate cyclase, cGMP- cyclic guanosine monophosphate, mRNA- messenger ribonucleic acid 
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Table 4: Major experimental studies investigating the effect of RIC on preventing acute brain 
IRI  
Experimental  
study 
Experimental setting RIC protocol Effect of RIC 
Dave et al 2006 
53
  
 
Rat model of ASA for 8 min and 
assessment at 7 days. 
One 15 or 30 min episode of 
ischemia applied to both 
hindlimbs 48 hrs prior to ASA. 
 
Preservation of CA1 hippocampal neurones 
Gurcun et al 2006 
120
 
Rabbit model of abdominal aortic 
occlusion (40 min) and reflow (24 
hrs) to induce acute spinal cord IRI 
Two cycles of 5 min renal I 
and 15 min renal R. 
 
Improved neurological recovery. 
 
Zhao et al  2007 
121
 
 
Rat model of middle cerebral artery 
occlusion/reflow (2 hr I, 24 hr R). 
Three-10 min cycles of 
hindlimb IR 
Reduced neurological dysfunction score. 
Reduced cerebral infarct size when RIC given 
1,2 or 24 hrs prior to middle cerebral artery 
occlusion but not 12 or 48 hrs prior, confirming 
the two windows of neuroprotection with RIC.   
 
Rehni et al 2007 
122
 
Murine model of bilateral carotid 
artery occlusion (10 min I/24 hr R) 
One 15 min episode of 
intestinal IR 
 
Reduced cerebral infarct size  
Less deterioration in motor function and short-
term memory. 
RIC protection abrogated by antagonists of KATP 
channel and adenosine. 
 
Ren et al 2008 
123
 
 
Rat model of cerebral IRI 
(permanent left distal middle 
cerebral artery occlusion + bilateral 
common carotid artery occlusion 
for 30 minutes). 
Three-15 min cycles of 
hindlimb IR  
Reduced cerebral infarct size when RIC 
administered 24 hr, 12 hr and immediately prior 
to acute cerebral IRI. 
Ren et al 2009 
123
 
 
Rat model of permanent cerebral 
IRI (permanent left distal middle 
cerebral artery occlusion + bilateral 
common carotid artery occlusion 
for 30 minutes). 
Three-15 min cycles of 
hindlimb IR applied at the 
onset of cerebral reperfusion 
(RIPost).  
 
Reduced cerebral infarct size when RIC 
immediately and 3 hours after cerebral 
reperfusion but not at 6 hours after reperfusion. 
First demonstration that RIPost and delayed 
RIPost effect. 
RIC blocked by capsaicin and cycloheximide 
implicating afferent nerve stimulation and protein 
synthesis in the mechanism. 
 
Saxena et al 2009  
124
 
Rat model of transient GCI, 8 min 
bilateral common carotid artery 
occlusion and hypotension. 
Five-5 min cycles of hindlimb 
IR   
 
No effect on CA1 hippocampal neurones. 
This is probably because of the index ischemic 
event not being insufficient. 
Yannopoulos et al 
2010 
125
 
Piglet model of cardiopulmonary 
bypass and hypothermic 
circulatory arrest 
Four-5 min cycles of hindlimb 
IR  
 
Reduced cerebral lactate, glucose and glycerol 
levels. 
More rapid recovery of EEG activity. 
 
Xu et al 2011 
126
 
 
Rat model bilateral carotid artery 
occlusion (60 min I/5-8 days R ) 
Three-10 min cycles of 
hindlimb IR 
 
Improved neurocognitive function. 
Increased expression for anti-apoptotic protein 
Bcl2. 
 
Malhotra et al 
2011 
127
 
Rat model of middle cerebral artery 
occlusion (2 hrs) and reflow (24 
hrs) 
Three-10 min cycles of 
infrarenal aortic occlusion and 
reflow.  
 
Reduced cerebral infarct size when RIC stimulus 
applied 24 hrs but not 48 or 72 hrs prior to acute 
cerebral IRI.  
Improved neurological outcomes 
RIC protection abrogated by hexamethonium 
implicating a neural pathway in protection. 
 
Jensen et al 2011 
128
 
Piglet model of cardiopulmonary 
bypass and hypothermic 
circulatory arrest 
Four-5 min cycles to hindlimb 
IR   
 
Reduced cerebral lactate levels. 
Less cerebral injury on histological analysis. 
More rapid recovery of EEG activity. 
Improved neurological recovery. 
 
Zhou et al 2011 
129
 Neonatal rat model cerebral 
hypoxia (unilateral carotid ligation 
and 2 hrs of hypoxia) 
Four-10 min cycles of IR to 
both hindlimbs at the onset of 
cerebral reoxygenation/ 
reperfusion (RIPost). 
 
Reduced cerebral infarct size 
Improved neurological recovery. 
RIC blocked by naloxone and wortmannin 
implicating opioid receptor and PI3K signalling in 
protective response. 
RIC associated with PKB activation and less 
BAX. 
 
Hahn et al 2011 
130
 
Rat model of middle cerebral artery 
occlusion (2 hrs) and reflow (24 
hrs) 
Four-5 min cycles to hindlimb 
IR   
 
Reduced cerebral infarct size when RIC stimulus 
applied prior to and after the onset of cerebral 
ischemia. 
First demonstration that RIPerC in brain. 
Sun et al 2012 
131
 Rat model of middle cerebral artery 
occlusion (90 min) and reflow (72 
hrs) 
Three-5 min cycles of IR to 
both hindlimbs (RIPost).    
 
Reduced cerebral infarct size when RIC stimulus 
applied at 3 or 6 hours into reperfusion. 
RIC protection via mitochondrial KATP channel. 
 
Geng et al 2012 
132
 
Rat model of intracerebral 
haemorrhage using collagenase.  
Repeated episodes of IR to 
both hindlimbs.    
 
No beneficial effects on cerebral blood volumes, 
brain water content, Evans blue extravasations, 
and expressions of AQP-4 and MMP-9 or 
44 
 
neurological function at either 24 or 72 hrs. 
 
Wei et al 2012 
133
 
 
Rat model of permanent cerebral 
IRI (permanent left distal middle 
cerebral artery occlusion + bilateral 
common carotid artery occlusion 
for 30 minutes). 
 
Three-15 min cycles of 
hindlimb IR.  
 
Reduced cerebral infarct size at 2 and 60 days 
with improved neurological recovery at 2 months. 
Less cerebral edema and reduced blood brain-
barrier permeability. 
RIC protection via afferent neural pathway. 
Attenuated increase in inflammatory protein 
galectin-9 and T-cell immunoglobulin domain 
and Tim-3 and less iNOS and nitrosylation. 
 
Hu et al 2012 
134
 Rat model of middle cerebral artery 
occlusion (90 min) and reflow (72 
hrs) 
Three-5 min cycles of hindlimb 
IR  
 
Reduced cerebral infarct size when RIC stimulus 
applied at 3 or 6 hours into reperfusion. 
RIC protection via mitochondrial KATP channel. 
  
I-ischemia, R-reperfusion, IR-ischemia and reperfusion, IRI-ischemia-reperfusion injury, RIC-remote ischemic conditioning, RIPost- remote 
ischemic postconditioning, RIPerC- remote ischemic perconditioning, ASA- asphyxial cardiac arrest, GCI- global cerebral ischemia, CA1- cornu 
ammonis-1, KATP- adenosine triphosphate-sensitive potassium, EEG- electroencephalography, bcl-2- B-cell lymphoma-2, PI3K- 
phosphatidylinositol 3-kinase, PKB- protein kinase B, BAX- b-cell lymphoma-2-associated X protein, AQP4- aquaporin-4, MMP-9- matrix 
metallopeptidase-9, Tim-3- mucin-domain-containing molecule-3, iNOS- inducible nitric oxide synthase,  
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